Rosuvastatin decreased laminin expression (laminin-positive areas: 2435 ± 562 μm2/field in treated versus 9625 ± 1840 μm2/field in untreated HCC livers (P < .001) (Figure 3(d)). The gene discussed is LAMB2; the disease is hepatocellular carcinoma.